ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis
Conference Coverage
Eculizumab reduces relapse-related hospitalizations in patients with NMOSD
WEST PALM BEACH, FLA. – The monoclonal antibody may reduce health care resource utilization in this patient...
Conference Coverage
Serum NfL levels may predict 10-year deep gray matter volumes
WEST PALM BEACH FLA. – Levels of NfL during the first 5 years after MS onset are associated with the volumes of the...
Conference Coverage
Phase 2 remyelination trial yields ‘intriguing’ interim results
WEST PALM BEACH, FLA. – VISIONARY-MS has enrolled patients at centers in Australia and recently expanded the trial sites in North America.
Conference Coverage
Cancer increase observed in modern era of MS drugs
WEST PALM BEACH, FLA. – The increased incidence is observed post 1996; the risk is nevertheless called small.
Conference Coverage
Key differences found between pediatric- and adult-onset MS
WEST PALM BEACH, FLA. – Patients with pediatric-onset MS have less higher education and greater use of highly...
Conference Coverage
Increased risk of infection seen in patients with MS
WEST PALM BEACH, FLA. – Multiple sclerosis is associated with increased risk for infection, including renal tract infection and hospitalized...
Conference Coverage
Pregnancy linked to slowed MS progression
WEST PALM BEACH, FLA. – The study shows women with no full-term pregnancies have earlier onset of progressive MS; the effect appears greater with...
Conference Coverage
OCT may help predict disease activity in CIS
WEST PALM BEACH, FLA. – Low ganglion cell and inner plexiform layer thickness is associated with an increased risk...
Conference Coverage
The art of selecting an MS therapy
DALLAS – Clinical and imaging findings may indicate disease phase, severity, and prognosis, which can inform the treatment choice.
Conference Coverage
A blood biomarker for MS: Coming to clinics soon?
DALLAS – Neurologists have lacked ways to monitor subclinical MS, but new developments suggest that blood levels of neurofilament light chain (NfL...
Conference Coverage
Cerebellar volume may predict disability in patients with relapsing-remitting MS
DALLAS – Baseline cerebellar gray matter volume was the only MRI metric that significantly predicted 25-foot walk test results at 36 months.
Conference Coverage
Imaging mass cytometry sheds light on inflammation, demyelination in MS
DALLAS – The technology enables clinicians to examine multiple proteins within intact tissue and distinguish cell types based on complex...
Conference Coverage
MS researchers aim to build MRI diagnostic portfolio beyond the central vein sign
DALLAS – Evaluation of lesion morphology is one emerging technology, according to Dr. Andrew J. Solomon.
Conference Coverage
Study launched to further evaluate the central vein sign in MS
DALLAS – A total of 10 clinical sites in North America are participating, with the Cleveland Clinic coordinating.
Conference Coverage
Expert calls for more ‘ethnocentric’ research in MS
DALLAS – Understanding the effect of race/ethnicity is crucial to understanding MS disparities.